Verdeso FDA Approval History
FDA Approved: Yes (First approved September 19, 2006)
Brand name: Verdeso
Generic name: desonide
Dosage form: Foam
Company: Connetics Corporation
Treatment for: Dermatitis
Verdeso (desonide) Foam is a low-potency topical steroid formulated in VersaFoam emulsion foam drug delivery vehicle for the treatment of mild-to-moderate atopic dermatitis.
Development timeline for Verdeso
|Sep 19, 2006||Approval Verdeso Connetics Corporation - Treatment for Mild-to-Moderate Atopic Dermatitis|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.